Bios Partners

Bios Partners is a venture capital firm identifying advanced biotech in overlooked and under-invested markets in the U.S., which our team helps cultivate and bring to market. Bios Investment thesis is based on three pillars. 1. Disrupting The Geographic Favoritism Bios identified a dearth of venture funding in the Central United States, where an abundance of innovative science is being continually developed. 2. Investment Activism Bios actively cultivates companies by leveraging our internal team’s deep and diverse experience to support our companies in many ways that traditional venture partners do not. Great science may never meet the marketplace due to a lack of early-stage business acumen. Bios bridges this gap by helping management teams focus on their highest and best use by supplementing incremental operational gaps, allowing for incremental value creation. 3. Collective Experience Bios Partners has a combined 90+ years of experience in hedge funds, private equity, clinical drug development, and public pharma/biotech analysis to fill the CEO’s experiential void.